DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report)’s stock price hit a new 52-week low on Tuesday . The company traded as low as $100.26 and last traded at $100.26, with a volume of 50 shares changing hands. The stock had previously closed at $102.64.
Analyst Ratings Changes
Separately, UBS Group downgraded shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th.
Get Our Latest Analysis on DiaSorin
DiaSorin Trading Down 2.3 %
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Read More
- Five stocks we like better than DiaSorin
- When to Sell a Stock for Profit or Loss
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- The Role Economic Reports Play in a Successful Investment Strategy
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Overbought Stocks Explained: Should You Trade Them?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.